Nothing Special   »   [go: up one dir, main page]

CN108610352A - A kind of method that solvent crystal prepares mezlocillin sodium - Google Patents

A kind of method that solvent crystal prepares mezlocillin sodium Download PDF

Info

Publication number
CN108610352A
CN108610352A CN201810603658.XA CN201810603658A CN108610352A CN 108610352 A CN108610352 A CN 108610352A CN 201810603658 A CN201810603658 A CN 201810603658A CN 108610352 A CN108610352 A CN 108610352A
Authority
CN
China
Prior art keywords
mezlocillin
sodium
acetone
present
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810603658.XA
Other languages
Chinese (zh)
Other versions
CN108610352B (en
Inventor
曲永科
成继民
马国庆
徐量
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amicogen China Biopharm Co Ltd
Original Assignee
Shandong Lukang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Lukang Pharmaceutical Co Ltd filed Critical Shandong Lukang Pharmaceutical Co Ltd
Priority to CN201810603658.XA priority Critical patent/CN108610352B/en
Publication of CN108610352A publication Critical patent/CN108610352A/en
Application granted granted Critical
Publication of CN108610352B publication Critical patent/CN108610352B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/68Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with aromatic rings as additional substituents on the carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/14Preparation of salts
    • C07D499/16Preparation of salts of alkali or alkaline earth metals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/18Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a kind of solvent crystals to prepare mezlocillin sodium method, including following preparation process:1) mezlocillin, acetone, water and sodium iso-octoate are mixed to get mixed liquor;2) after mixed liquor heating up mezlocillin sodium is mixed to get with acetone.The present invention is by being used only same solvent in entire technical process, the product mezlocillin sodium yield for solving the problems, such as mixed solvent, and obtaining is up to 80~95%, purity 99.2~99.8%, and total miscellaneous 0.05~0.15%.

Description

A kind of method that solvent crystal prepares mezlocillin sodium
Technical field
The present invention relates to a kind of methods that technical field of medicine synthesis more particularly to solvent crystal prepare mezlocillin sodium.
Background technology
Mezlocillin sodium, English name mezlocillinsodium are one of national essential drugs, belong to the third generation half Syncillin class antibacterials are a kind of irreversible beta-lactamase inhibitors, to escherichia coli, proteus, copper Green pseudomonad, Klebsiella Pneumoniae, Enterobacter, neisseria gonorrhoeae, Neisseria meningitidis, streptococcus and bacteroid Category etc. has antibacterial action.Mezlocillin sodium has very strong anti-infectious function, for treating lower respiratory tract infection, skin sense Dye, urinary system infection contamination, intraperitoneal infection etc..
The preparation method of mezlocillin for injection mainly has freeze-drying, solvent crystallization, solventing-out process 3 at present Kind.Wherein solvent crystallization refers to dissolving product suitable medium (be typically all organic solvent) is inner, then passes through reduction The conditions such as temperature or the amount of reduction solvent make product reach hypersaturated state in solvent, to which the crystallization of product slowly be precipitated Journey.The method is affected between having used the various vehicle components of double solvent in process of production with comparison crystal structure process, And it is unfavorable for solvent recycling.
Invention content
In view of this, present invention aims at provide a kind of method that solvent crystal prepares mezlocillin sodium, whole process Using only same solvent, it is conducive to solvent and recycles, solve the problems, such as mixed solvent.
In order to achieve the above-mentioned object of the invention, the present invention provides following technical scheme:
A kind of solvent crystal prepares mezlocillin sodium method, includes the following steps:
1) mezlocillin, acetone, water and sodium iso-octoate are subjected to neutralization reaction, obtain reaction solution;
2) it is mixed with acetone after the reaction solution that the step (1) obtains heating up, obtains mezlocillin sodium.
Preferably, the amount ratio of mezlocillin in the step 1), acetone, water and sodium iso-octoate is 1kg:3~8L: 0.1-1kg:0.2~0.5kg.
Preferably, in the step 2), the amount ratio of acetone and mezlocillin in step 1) is 3-9L:1kg.
Preferably, the temperature after the reaction solution heating is 10~40 DEG C.
Preferably, the source of the mezlocillin includes the mezlocillin for meeting intermediate quality standard
Advantageous effects:Mezlocillin sodium method is prepared the present invention provides a kind of solvent crystal, and the present invention will will be beautiful Lip river XiLin acid, acetone, water and sodium iso-octoate carry out neutralization reaction, obtain reaction solution.It mixes, obtains with acetone after reaction solution heating Mezlocillin sodium.Same solvent acetone is used only in whole process, and solvent recycling (is by moisture height, the underproof acetone of content The high acetone of the low content of acetone of moisture is obtained by rectifying column rectifying, for producing).Solve the problems, such as mixed solvent, and And obtained product mezlocillin sodium yield is up to 80~95%, purity 99.2~99.8%, total miscellaneous 0.05~0.15%.
Specific implementation mode
The present invention provides a kind of solvent crystals to prepare mezlocillin sodium method, includes the following steps:
1) mezlocillin, acetone, water and sodium iso-octoate are subjected to neutralization reaction, obtain reaction solution;
2) it is mixed with acetone after the reaction solution that the step 1) obtains heating up, obtains mezlocillin sodium.
Mezlocillin, acetone, water and sodium iso-octoate are carried out neutralization reaction by the present invention, obtain reaction solution;
In the present invention, the amount ratio of the mezlocillin, acetone, water and sodium iso-octoate is 1kg:3~8L:0.1- 1kg:0.2~0.5kg, more preferably 1kg:5~7L:0.3-0.7kg:0.2-0.5kg.
In the present invention, the water is preferably purified water.
Mezlocillin dissolving is preferably formed mezlocillin acetone soln by the specific present invention in acetone, then again Water is added to be stirred, adds sodium iso-octoate and carries out neutralization reaction.
In the present invention, the rate of the stirring is preferably 20~50Hz, more preferably 45Hz, and the time of stirring is preferably 30min~50min, more preferably 35min~45min.
In the present invention, it is preferred to be added after mezlocillin dissolving is formed mezlocillin acetone soln in acetone Water.Sodium iso-octoate is added, generates mezlocillin sodium.
In the present invention, the reaction temperature of the neutralization reaction is preferably room temperature;The time of the neutralization reaction is preferably 30min~120min, more preferably 60min.In the present invention, when the time of the neutralization reaction is completely dissolved with sodium iso-octoate Start to calculate.
In the present invention, the source of the mezlocillin includes the mezlocillin for meeting intermediate quality standard.
After obtaining reaction solution, is mixed with acetone after reaction solution heating of the present invention, obtain mezlocillin sodium.
In the present invention, the mass ratio of the mezlocillin and acetone is preferably 1kg:3~8L, more preferably 1kg: 7L。
In the present invention, preferably 25~35 DEG C, more preferably 28~30 DEG C of the reacting liquid temperature control.
In the present invention, after the mezlocillin sodium crystallization, crystal solution is filtered, obtained solid is dried to obtain Mei Luoxi Woods sodium finished product.
In the present invention, the temperature of the drying is preferably 30~80 DEG C, more preferably 50-70 DEG C, the drying when Between preferably 1~6 hour, more preferably 2-4 hours.
For a better understanding of the present invention, with reference to the embodiment content that the present invention is furture elucidated, but the present invention Content is not limited solely to the following examples.
Embodiment 1
After putting into mezlocillin 134kg addition 670L acetone solutions, it is added after 134kg purified waters stirring half an hour is added 40.2kg sodium iso-octoates are completely dissolved 25 DEG C of rear temperature control, add 1200L acetone, stir mezlocillin sodium crystal after half an hour It is precipitated, goes out mezlocillin sodium product 131kg after filtration washing drying.Product yield 94%, purity 99.78%, total miscellaneous 0.2%.
Embodiment 2
After putting into mezlocillin 134kg addition 402L acetone solutions, it is added after 67kg purified waters stirring half an hour is added 46.9kg sodium iso-octoates are completely dissolved 27 DEG C of rear temperature control, add 804L acetone, stir mezlocillin sodium crystal analysis after half an hour Go out, goes out mezlocillin sodium product 133.9kg after filtration washing drying.Product yield 96%, purity 99.82%, total miscellaneous 0.2%.
Embodiment 3
After putting into mezlocillin 134kg addition 1072L acetone solutions, add after 13.4kg purified waters stirring half an hour is added Enter 43.3kg sodium iso-octoates, be completely dissolved 30 DEG C of rear temperature control, add 410L acetone, stirs mezlocillin sodium crystal after half an hour It is precipitated, goes out mezlocillin sodium product 129.4kg after filtration washing drying.Product yield 92.78%, purity 99.91 are total miscellaneous 0.1%.
The above is only a preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art For member, various improvements and modifications may be made without departing from the principle of the present invention, these improvements and modifications are also answered It is considered as protection scope of the present invention.

Claims (5)

1. a kind of solvent crystal prepares mezlocillin sodium method, include the following steps:
1) mezlocillin, acetone, water and sodium iso-octoate are subjected to neutralization reaction, obtain reaction solution;
2) it is mixed with acetone after the reaction solution that the step (1) obtains heating up, obtains mezlocillin sodium.
2. according to the method described in claim 1, it is characterized in that, in the step 1), mezlocillin, acetone, water with it is different The amount ratio of Sodium Caprylate is 1kg:3~8L:0.1-1kg:0.2~0.5kg.
3. according to the method described in claim 1, it is characterized in that, mezlocillin in acetone and step 1) in the step 2) Mass ratio be 3-9L:1kg.
4. according to the method described in claim 1, it is characterized in that, in the step 2), the temperature after reaction solution heating is 10 ~40 DEG C.
5. according to the method described in claim 1, it is characterized in that, the source of the mezlocillin includes meeting intermediate constitution The mezlocillin of amount standard.
CN201810603658.XA 2018-06-12 2018-06-12 Method for preparing mezlocillin sodium by solvent crystallization Active CN108610352B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810603658.XA CN108610352B (en) 2018-06-12 2018-06-12 Method for preparing mezlocillin sodium by solvent crystallization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810603658.XA CN108610352B (en) 2018-06-12 2018-06-12 Method for preparing mezlocillin sodium by solvent crystallization

Publications (2)

Publication Number Publication Date
CN108610352A true CN108610352A (en) 2018-10-02
CN108610352B CN108610352B (en) 2020-08-04

Family

ID=63665095

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810603658.XA Active CN108610352B (en) 2018-06-12 2018-06-12 Method for preparing mezlocillin sodium by solvent crystallization

Country Status (1)

Country Link
CN (1) CN108610352B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113121569A (en) * 2021-04-20 2021-07-16 海南通用三洋药业有限公司 Preparation method of mezlocillin sodium

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101570543A (en) * 2009-06-04 2009-11-04 浙江工业大学 Preparation method of mezlocillin sodium solvent crystal
CN101654457A (en) * 2009-08-07 2010-02-24 菏泽睿鹰制药集团有限公司 Method for synthesizing mezlocillin sodium through solvent method
CN102161666A (en) * 2011-04-08 2011-08-24 苏州二叶制药有限公司 Preparation method of mezlocillin sodium and mezlocillin sodium for injection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101570543A (en) * 2009-06-04 2009-11-04 浙江工业大学 Preparation method of mezlocillin sodium solvent crystal
CN101654457A (en) * 2009-08-07 2010-02-24 菏泽睿鹰制药集团有限公司 Method for synthesizing mezlocillin sodium through solvent method
CN102161666A (en) * 2011-04-08 2011-08-24 苏州二叶制药有限公司 Preparation method of mezlocillin sodium and mezlocillin sodium for injection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113121569A (en) * 2021-04-20 2021-07-16 海南通用三洋药业有限公司 Preparation method of mezlocillin sodium

Also Published As

Publication number Publication date
CN108610352B (en) 2020-08-04

Similar Documents

Publication Publication Date Title
CN108329205B (en) Preparation method of bis (2-acetoxybenzoic acid) calcium urea compound
CN108125245B (en) Preparation method of phycocyanin microcapsule
CN107108443A (en) The improved method for synthesizing ferric organic compounds
CN103880625A (en) Method for preparing D, L-mandelic acid and derivative of D, L-mandelic acid
SE458118B (en) PROCEDURES FOR THE PREPARATION OF AN INJECTABLE CONDROITIN POLYSULPHATE, A PRODUCT THAT CAN BE RECOVERED BY THIS PROCEDURE AND A PHARMACEUTICAL COMPOSITION
CN112442084B (en) Preparation method of antibacterial drug intermediate
CN101117240A (en) Preparation method of solid potassium ferrate
CN108610352A (en) A kind of method that solvent crystal prepares mezlocillin sodium
CN102372626B (en) Preparation method of phthalic acid
CN109608328A (en) A kind of preparation method of injection calcium gluconate
US3091626A (en) Method of making ferrous citrate
CN108017561B (en) Method for refining carglutamic acid
CN102503810B (en) Method for recovering and recycling L-tartaric acid
CN107572588A (en) A kind of environment-friendly type sodium tungstate preparation technology and its application
CN107235919A (en) A kind of synthesis technique of minoxidil
CN106883202A (en) A kind of preparation method of L ascorbyl palmitates
CN106966916A (en) A kind of method that terramycin reduces tailing peak content
CN105001353A (en) Refining optimization technology for crude heparin sodium
DE102018133528A1 (en) Process for preparing boron trifluoride monoethylamine complex
CN110407737B (en) Preparation method of cyproheptadine hydrochloride
CN109293631B (en) Preparation method of 3-amino-N- (2, 6-dioxo-3-piperidyl) -phthalimide compound
CN101633639B (en) High-purity fleroxacin compound
CN110878056A (en) Novel method for synthesizing 2-amino-3, 5-dibromopyrazine, product and application
CN108610303A (en) The synthetic method of dibenzothiazyl disulfide
DE1081880B (en) Process for the production of titanium (III) acetylacetonate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant